Treatment of HER2-positive metastatic breast cancer.
Citation: New England Journal of Medicine. 372(20):1964-5, 2015 May 14.PMID: 25970056Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Comment | LetterSubject headings: *Antibodies, Monoclonal, Humanized/ad [Administration & Dosage] | *Antineoplastic Combined Chemotherapy Protocols/tu [Therapeutic Use] | *Breast Neoplasms/dt [Drug Therapy] | *Neoplasm Metastasis/dt [Drug Therapy] | *Taxoids/ad [Administration & Dosage] | Female | HumansYear: 2015Local holdings: Available online from MWHC library: 1993 - present, Available in print through MWHC library: 1980 - presentISSN:- 0028-4793
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 25970056 | Available | 25970056 |
Available online from MWHC library: 1993 - present, Available in print through MWHC library: 1980 - present
English